Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma.
Paola TodescaLuca MarziRosina Maria CritelliBiagio CuffariCristian CaporaliLaura TurcoGiovanni PinelliFilippo SchepisLucia CarulliNicola de MariaFederico CasariRiccardo ScaglioniErica VillaPublished in: Hepatology (Baltimore, Md.) (2019)
Keyphrases